Novo Nordisk (NVO) stock forecast for 2026. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Novo Nordisk (NVO) stock forecast for 2026

Updated: March 26, 2024 (06:38)

Sector: Healthcare

The share price of Novo Nordisk A/S (NVO) now

What analysts predict: $140.74
52-week High/Low: $137.57 / $74.92

50/200 Day Moving Average: $120.1 / $99.39

This figure corresponds to the Average Price over the previous 50/200 days. For Novo Nordisk stocks, the 50-day moving average is the resistance level today.

For Novo Nordisk stocks, the 200-day moving average is the resistance level today.

Are you interested in Novo Nordisk A/S stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Novo Nordisk stock price in 2026. How much will one Novo Nordisk share be worth in 2026? Is it worth taking profit / loss on NVO stock now or waiting? What are analysts' forecasts for Novo Nordisk stock?

We forecast Novo Nordisk stock performance using neural networks based on historical data on NVO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Novo Nordisk A/S stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Novo Nordisk analysts is $140.74. Today 200 Day Moving Average is the support level (99.39 $). 50 Day Moving Average is the support level (120.1 $).




Historical and forecast chart of Novo Nordisk A/S stock

The chart below shows the historical price of Novo Nordisk stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the NVO stock price can be found in the table below.


Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Novo Nordisk (NVO) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 164.05 153.68 166.67 7.79 %
Feb 168.90 158.77 176.20 9.89 %
Mar 162.42 155.53 171.64 9.39 %
Apr 161.12 154.29 164.47 6.19 %
May 159.57 156.13 163.40 4.45 %
Jun 156.89 148.98 161.28 7.63 %
Jul 146.10 141.19 153.81 8.21 %
Aug 139.90 134.08 148.74 9.86 %
Sep 135.31 131.85 141.05 6.52 %
Oct 132.93 128.36 140.27 8.49 %
Nov 129.00 121.98 133.43 8.58 %
Dec 125.39 118.26 132.01 10.41 %

Novo Nordisk information and performance

Novo Nordisk Address

NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK

Market Capitalization: 579 007 873 000 $

Market capitalization of the Novo Nordisk A/S is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVO shares in the company outstanding by the market price of one share.

EBITDA: 109 812 998 000 $

EBITDA of Novo Nordisk is earnings before interest, income tax and depreciation of assets.

PE Ratio: 47.37

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.338

Price/earnings to growth

DPS: 9.4

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0107

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.73

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.631
Quarterly Revenue Growth YOY: 0.37
Trailing PE: 47.37

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 38.02

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.48

Enterprise Value (EV) /Revenue

EV To EBITDA: 5.03

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 4462230000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Novo Nordisk price target for 2026 by month


Target values for the price of one Novo Nordisk share for Jan 2026.

The weighted average target price per Novo Nordisk share in Jan 2026 is: 164.05.
In Jan, the Positive dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 7.795% volatility is expected.
Pessimistic target level: 153.68
Optimistic target level: 166.67

Target values for the price of one Novo Nordisk share for Feb 2026.

The weighted average target price per Novo Nordisk share in Feb 2026 is: 168.90.
In Feb, the Positive dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 9.893% volatility is expected.
Pessimistic target level: 158.77
Optimistic target level: 176.20

Target values for the price of one Novo Nordisk share for Mar 2026.

The weighted average target price per Novo Nordisk share in Mar 2026 is: 162.42.
In Mar, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 9.387% volatility is expected.
Pessimistic target level: 155.53
Optimistic target level: 171.64

Target values for the price of one Novo Nordisk share for Apr 2026.

The weighted average target price per Novo Nordisk share in Apr 2026 is: 161.12.
In Apr, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 6.191% volatility is expected.
Pessimistic target level: 154.29
Optimistic target level: 164.47

Target values for the price of one Novo Nordisk share for May 2026.

The weighted average target price per Novo Nordisk share in May 2026 is: 159.57.
In May, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 4.453% volatility is expected.
Pessimistic target level: 156.13
Optimistic target level: 163.40

Target values for the price of one Novo Nordisk share for Jun 2026.

The weighted average target price per Novo Nordisk share in Jun 2026 is: 156.89.
In Jun, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 7.626% volatility is expected.
Pessimistic target level: 148.98
Optimistic target level: 161.28

Target values for the price of one Novo Nordisk share for Jul 2026.

The weighted average target price per Novo Nordisk share in Jul 2026 is: 146.10.
In Jul, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 8.206% volatility is expected.
Pessimistic target level: 141.19
Optimistic target level: 153.81

Target values for the price of one Novo Nordisk share for Aug 2026.

The weighted average target price per Novo Nordisk share in Aug 2026 is: 139.90.
In Aug, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 9.857% volatility is expected.
Pessimistic target level: 134.08
Optimistic target level: 148.74

Target values for the price of one Novo Nordisk share for Sep 2026.

The weighted average target price per Novo Nordisk share in Sep 2026 is: 135.31.
In Sep, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 6.523% volatility is expected.
Pessimistic target level: 131.85
Optimistic target level: 141.05

Target values for the price of one Novo Nordisk share for Oct 2026.

The weighted average target price per Novo Nordisk share in Oct 2026 is: 132.93.
In Oct, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 8.491% volatility is expected.
Pessimistic target level: 128.36
Optimistic target level: 140.27

Target values for the price of one Novo Nordisk share for Nov 2026.

The weighted average target price per Novo Nordisk share in Nov 2026 is: 129.00.
In Nov, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 8.585% volatility is expected.
Pessimistic target level: 121.98
Optimistic target level: 133.43

Target values for the price of one Novo Nordisk share for Dec 2026.

The weighted average target price per Novo Nordisk share in Dec 2026 is: 125.39.
In Dec, the Negative dynamics for Novo Nordisk A/S shares will prevail with possible monthly volatility of 10.410% volatility is expected.
Pessimistic target level: 118.26
Optimistic target level: 132.01



Novo Nordisk (NVO) stock dividend

Novo Nordisk last paid dividends on 03/22/2024. The next scheduled payment will be on 04/02/2024. The amount of dividends is $9.4 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.